|
US20040116350A1
(en)
*
|
2001-09-17 |
2004-06-17 |
Paul Wentworth Jr |
Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies
|
|
US20050129680A1
(en)
*
|
2001-09-17 |
2005-06-16 |
Paul Wentworth |
Antimicrobial activity of antibodies
|
|
US20040157280A1
(en)
*
|
2001-09-17 |
2004-08-12 |
Paul Wentworth |
Antibody mediated ozone generation
|
|
MX339524B
(es)
|
2001-10-11 |
2016-05-30 |
Wyeth Corp |
Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
|
|
WO2004044582A2
(en)
*
|
2002-11-14 |
2004-05-27 |
Novartis Ag |
Antibody- or neutrophil-mediated ozone generation
|
|
GB0313916D0
(en)
|
2003-06-16 |
2003-07-23 |
Glaxosmithkline Biolog Sa |
Vaccine composition
|
|
JP4860109B2
(ja)
*
|
2003-12-26 |
2012-01-25 |
バイオリーダース・コーポレイション |
ポリガンマグルタミン酸を含む免疫増強用組成物
|
|
DE102006047617B4
(de)
*
|
2006-10-09 |
2008-11-27 |
Clariant International Limited |
Verfahren zur Herstellung basischer (Meth)acrylamide
|
|
US20090017064A1
(en)
*
|
2007-07-10 |
2009-01-15 |
Wyeth |
Methods and Compositions for Immunizing Pigs Against Porcine Circovirus
|
|
FR2922767B1
(fr)
*
|
2007-10-24 |
2009-12-18 |
Seppic Sa |
Procede de preparation d'une composition vaccinale comprenant au moins un antigene et au moins un adjuvant.
|
|
ME01000B
(me)
|
2007-11-06 |
2012-10-20 |
Zoetis Services Llc |
Živa vakcina avirulentne mycoplasma hyopneumoniae sa adjuvansom
|
|
EP2062594A1
(en)
*
|
2007-11-21 |
2009-05-27 |
Wyeth Farma, S.A. |
Bluetongue virus vaccine and immunogenic compositions, methods of use and methods of producing same
|
|
DE102008017216B4
(de)
*
|
2008-04-04 |
2013-08-14 |
Clariant International Ltd. |
Kontinuierliches Verfahren zur Herstellung von Fettsäureamiden
|
|
TW201010719A
(en)
*
|
2008-08-19 |
2010-03-16 |
Wyeth Corp |
Immunological composition
|
|
GB0907989D0
(en)
|
2009-05-08 |
2009-06-24 |
Hybrid Systems Ltd |
Multivalent adjuvant display
|
|
SI2445522T1
(sl)
|
2009-06-22 |
2017-10-30 |
Wyeth Llc |
Imunogeni sestavki antigenov Staphylococcusa aureusa
|
|
EP3461496B1
(en)
|
2009-06-22 |
2023-08-23 |
Wyeth LLC |
Compositions and methods for preparing staphylococcus aureus serotype 5 and 8 capsular polysaccharide conjugate immunogenic compositions
|
|
DE102009031059A1
(de)
|
2009-06-30 |
2011-01-05 |
Clariant International Ltd. |
Vorrichtung zur kontinuierlichen Durchführung chemischer Reaktionen bei hohen Temperaturen
|
|
US20110110980A1
(en)
|
2009-09-02 |
2011-05-12 |
Wyeth Llc |
Heterlogous prime-boost immunization regimen
|
|
DE102009042522A1
(de)
|
2009-09-22 |
2011-04-07 |
Clariant International Ltd. |
Kontinuierliches Umesterungsverfahren
|
|
DE102009042523B4
(de)
|
2009-09-22 |
2012-02-16 |
Clariant International Ltd. |
Vorrichtung und Verfahren zur kontinuierlichen Durchführung heterogen katalysierter chemischer Reaktionen bei hohen Temperaturen
|
|
US20130310462A1
(en)
|
2010-08-04 |
2013-11-21 |
Tixupharma |
Supramolecular complexes of polyanionic polymers and spermidine in tissue maintenance and repair
|
|
PT3246044T
(pt)
|
2010-08-23 |
2021-02-15 |
Wyeth Llc |
Formulações estáveis de antigénios de rlp2086 de neisseria meningitidis
|
|
AU2011300409B2
(en)
|
2010-09-10 |
2015-03-26 |
Wyeth Llc |
Non-lipidated variants of Neisseria meningitidis ORF2086 antigens
|
|
PT2654784T
(pt)
|
2010-12-22 |
2017-02-13 |
Wyeth Llc |
Composições imunogénicas estáveis de antigénios de staphylococcus aureus
|
|
DE102010056564A1
(de)
|
2010-12-30 |
2012-07-05 |
Clariant International Limited |
Hydroxylgruppen und Estergruppen tragende Polymere und Verfahren zu ihrer Herstellung
|
|
DE102010056565A1
(de)
|
2010-12-30 |
2012-07-05 |
Clariant International Ltd. |
Verfahren zur Modifizierung Hydroxylgruppen tragender Polymere
|
|
DE102010056566A1
(de)
*
|
2010-12-30 |
2012-07-05 |
Clariant International Ltd. |
Kontinuierliches Verfahren zur Veresterung Säuregruppen tragender Polymere
|
|
SA115360586B1
(ar)
|
2012-03-09 |
2017-04-12 |
فايزر انك |
تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
|
|
US8986710B2
(en)
|
2012-03-09 |
2015-03-24 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|
|
US9120859B2
(en)
|
2012-04-04 |
2015-09-01 |
Zoetis Services Llc |
Mycoplasma hyopneumoniae vaccine
|
|
UA114503C2
(uk)
|
2012-04-04 |
2017-06-26 |
Зоетіс Сервісіз Ллс |
Комбінована вакцина pcv та mycoplasma hyopneumoniae
|
|
UA114504C2
(uk)
|
2012-04-04 |
2017-06-26 |
Зоетіс Сервісіз Ллс |
Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
|
|
CN104870463B
(zh)
|
2012-12-20 |
2018-09-28 |
辉瑞公司 |
糖缀合方法
|
|
WO2014136064A2
(en)
|
2013-03-08 |
2014-09-12 |
Pfizer Inc. |
Immunogenic fusion polypeptides
|
|
MX369534B
(es)
|
2013-09-08 |
2019-11-11 |
Pfizer |
Composiciones de neisseria meningitidis y sus metodos.
|
|
RU2662685C2
(ru)
|
2013-09-25 |
2018-07-26 |
Зоэтис Сервисиз Ллс |
Pcv2b дивергентная вакцинная композиция и способы её применения
|
|
RU2723045C2
(ru)
|
2015-02-19 |
2020-06-08 |
Пфайзер Инк. |
Композиции neisseria meningitidis и способы их получения
|
|
IL255106B2
(en)
|
2015-05-04 |
2023-04-01 |
Pfizer |
Protein-polysaccharide conjugates of group b streptococcus, methods for preparing conjugates, immunogenic preparations containing conjugates and their uses
|
|
HRP20250077T1
(hr)
*
|
2016-06-17 |
2025-03-28 |
Boehringer Ingelheim Vetmedica Gmbh |
Nove imunogene formulacije koje sadrže ravne ili razgranate polimerne adjuvante poliakrilne kiseline
|
|
US10751402B2
(en)
|
2016-11-09 |
2020-08-25 |
Pfizer Inc. |
Immunogenic compositions and uses thereof
|
|
SG10202111092UA
(en)
|
2017-01-31 |
2021-11-29 |
Pfizer |
Neisseria meningitidis compositions and methods thereof
|
|
JP7497293B2
(ja)
|
2018-03-16 |
2024-06-10 |
ゾエティス・サービシーズ・エルエルシー |
インターロイキン－３１に対するペプチドワクチン
|
|
CN109134724A
(zh)
*
|
2018-07-24 |
2019-01-04 |
石家庄哈顿生物技术有限公司 |
一种动物疫苗用聚丙烯酸类聚合物佐剂的研制方法
|
|
CA3155669A1
(en)
|
2019-09-27 |
2021-04-01 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|
|
JP2023538736A
(ja)
|
2020-08-26 |
2023-09-11 |
ファイザー・インク |
Ｂ群レンサ球菌多糖－タンパク質コンジュゲート、コンジュゲートを生成するための方法、コンジュゲートを含む免疫原性組成物、およびそれらの使用
|